Real-time enrollment status for this lennox-gastaut syndrome clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 10:27 PM UTC
| NCT Number | NCT05066217 |
| Recruiting Status | Recruiting |
| Condition | Lennox-Gastaut Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 260 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Epygenix |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT05066217 is currently recruiting participants. This phase3 study for lennox-gastaut syndrome is actively seeking new participants at 21 locations across the United States. The study is sponsored by Epygenix. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05066217 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05066217 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.